Mandelin Cooper

791 total citations
16 papers, 123 citations indexed

About

Mandelin Cooper is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Geriatrics and Gerontology. According to data from OpenAlex, Mandelin Cooper has authored 16 papers receiving a total of 123 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Applied Microbiology and Biotechnology, 4 papers in Infectious Diseases and 4 papers in Geriatrics and Gerontology. Recurrent topics in Mandelin Cooper's work include Antibiotic Use and Resistance (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mandelin Cooper is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mandelin Cooper collaborates with scholars based in United States, Australia and United Kingdom. Mandelin Cooper's co-authors include David G. Brock, L. Hayley Burgess, Jeanine M. Walenga, Geno J. Merli, Benjamin E. Leiby, Jonathan E. Gottlieb, Gregg Fromell, Edward Septimus, Pratik Doshi and Kenneth Sands and has published in prestigious journals such as Gastroenterology, American Journal of Infection Control and Annals of Pharmacotherapy.

In The Last Decade

Mandelin Cooper

15 papers receiving 117 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandelin Cooper United States 7 28 20 19 18 18 16 123
Andrés Gaviria‐Mendoza Colombia 10 43 1.5× 34 1.7× 33 1.7× 33 1.8× 32 1.8× 77 282
Luis Fernando Valladales‐Restrepo Colombia 9 41 1.5× 38 1.9× 40 2.1× 34 1.9× 35 1.9× 64 241
Matthew F Emons United States 10 53 1.9× 29 1.4× 96 5.1× 34 1.9× 14 0.8× 17 352
Corinne Dupont France 7 27 1.0× 11 0.6× 24 1.3× 8 0.4× 24 1.3× 10 293
Nada S. Al‐Qadheeb United States 11 7 0.3× 12 0.6× 19 1.0× 9 0.5× 22 1.2× 23 345
Ameha Zewudie Ethiopia 10 18 0.6× 5 0.3× 56 2.9× 10 0.6× 36 2.0× 16 248
O Mimi Malaysia 9 81 2.9× 27 1.4× 91 4.8× 34 1.9× 17 0.9× 13 301
Fredrick Kalokola Tanzania 9 13 0.5× 14 0.7× 38 2.0× 3 0.2× 19 1.1× 17 152
Raphael Kazidule Kayambankadzanja Malawi 6 13 0.5× 11 0.6× 44 2.3× 9 0.5× 7 0.4× 9 157
Jalal Soleimani United States 10 35 1.3× 4 0.2× 34 1.8× 8 0.4× 6 0.3× 21 234

Countries citing papers authored by Mandelin Cooper

Since Specialization
Citations

This map shows the geographic impact of Mandelin Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandelin Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandelin Cooper more than expected).

Fields of papers citing papers by Mandelin Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandelin Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandelin Cooper. The network helps show where Mandelin Cooper may publish in the future.

Co-authorship network of co-authors of Mandelin Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Mandelin Cooper. A scholar is included among the top collaborators of Mandelin Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandelin Cooper. Mandelin Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
McFarland, M. Shawn, Kayla R. Stover, Shubha Bhat, et al.. (2023). Charting a new path forward for pharmacy residency expansion. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(2). 205–212. 2 indexed citations
2.
Burgess, L. Hayley, et al.. (2021). COVID-19: The Vaccine Race Continues. HCA Healthcare Journal of Medicine. 2(2). 81–91. 4 indexed citations
3.
Burgess, L. Hayley, et al.. (2021). Characteristics Contributing to a Pharmacy Services Excellence Model in a Large Health System. HCA Healthcare Journal of Medicine. 2(5). 367–378. 3 indexed citations
4.
5.
Burgess, L. Hayley, et al.. (2020). COVID-19: Race for Vaccine. HCA Healthcare Journal of Medicine. 1(6). 463–474. 2 indexed citations
6.
Burgess, L. Hayley, et al.. (2020). Utilizing Pharmacists to Optimize Medication Management Strategies During the COVID-19 Pandemic. Journal of Pharmacy Practice. 35(2). 184–189. 6 indexed citations
7.
Cooper, Mandelin, et al.. (2020). Process analysis of procalcitonin monitoring within community hospitals. American Journal of Health-System Pharmacy. 77(8). 632–635. 2 indexed citations
8.
Cooper, Mandelin, et al.. (2019). Analysis of antibiotic use in a large network of emergency departments. American Journal of Health-System Pharmacy. 76(21). 1753–1761. 4 indexed citations
9.
Burgess, L. Hayley, et al.. (2018). Phased implementation of an antimicrobial stewardship program for a large community hospital system. American Journal of Infection Control. 47(1). 69–73. 11 indexed citations
10.
Burgess, L. Hayley, et al.. (2018). Use of clinical decision support to identify i.v.-to-oral conversion opportunities and cost savings. American Journal of Health-System Pharmacy. 75(23_Supplement_4). S82–S86. 6 indexed citations
11.
Cooper, Mandelin, et al.. (2018). 1856. Comparison of Antibiotic Susceptibility in Hospitals vs. Hospital-Based Emergency Departments. Open Forum Infectious Diseases. 5(suppl_1). S530–S530. 1 indexed citations
12.
Bormans, Guy, Andreas K. Buck, Arturo Chiti, et al.. (2017). Position statement on radiopharmaceutical production for clinical trials. EJNMMI Radiopharmacy and Chemistry. 2(1). 12–12. 6 indexed citations
13.
Cooper, Mandelin, et al.. (2017). Navigating the New Antimicrobial Stewardship Regulations. Hospital Pharmacy. 52(8). 527–531.
14.
Cooper, Mandelin, et al.. (2015). Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam. Hospital Pharmacy. 50(5). 376–379. 13 indexed citations
15.
Cooper, Mandelin, et al.. (2008). Effectiveness of a clinical decision support system to identify heparin induced thrombocytopenia. Journal of Thrombosis and Thrombolysis. 28(2). 124–131. 21 indexed citations
16.
Cooper, Mandelin, et al.. (2008). Interaction Between Levodopa and Enteral Nutrition. Annals of Pharmacotherapy. 42(3). 439–442. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrés Gaviria‐Mendoza Breakdown of academic impact, for papers by Luis Fernando Valladales‐Restrepo Breakdown of academic impact, for papers by Matthew F Emons Breakdown of academic impact, for papers by Corinne Dupont Breakdown of academic impact, for papers by Nada S. Al‐Qadheeb Breakdown of academic impact, for papers by Ameha Zewudie Breakdown of academic impact, for papers by O Mimi Breakdown of academic impact, for papers by Fredrick Kalokola Breakdown of academic impact, for papers by Raphael Kazidule Kayambankadzanja Breakdown of academic impact, for papers by Jalal Soleimani
Rankless by CCL
2026